|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/095 | |
| C07K 14/22 |
| (11) | Patento numeris | 2331121 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09779121.4 |
| Europos patento paraiškos padavimo data | 2009-03-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-06-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/052689 |
| Data | 2009-03-06 |
| (87) | Numeris | WO 2010/025964 |
| Data | 2010-03-11 |
| (30) | Numeris | Data | Šalis |
| 0816447 | 2008-09-08 | GB |
| (72) |
BOS, Martine Petronella, NL
POOLMAN, Jan, BE
STORK, Michiel, NL
TOMMASSEN, Johannes Petrus Maria, NL
WEYNANTS, Vincent, BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
University of Utrecht, Department of Molecular & Cell Biology and Institute of Biomembranes Utrecht University Padulaan 8, 3548 CH Utrecht, NL |
| (54) | VACCINE COMPRISING PROTEIN NMBO964 FROM MEISSERIA MENINGITIDIS |
| VACCINE COMPRISING PROTEIN NMBO964 FROM MEISSERIA MENINGITIDIS |